BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 10097101)

  • 1. GADD45 induction of a G2/M cell cycle checkpoint.
    Wang XW; Zhan Q; Coursen JD; Khan MA; Kontny HU; Yu L; Hollander MC; O'Connor PM; Fornace AJ; Harris CC
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3706-11. PubMed ID: 10097101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a functional domain in a GADD45-mediated G2/M checkpoint.
    Yang Q; Manicone A; Coursen JD; Linke SP; Nagashima M; Forgues M; Wang XW
    J Biol Chem; 2000 Nov; 275(47):36892-8. PubMed ID: 10973963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity.
    Jin S; Tong T; Fan W; Fan F; Antinore MJ; Zhu X; Mazzacurati L; Li X; Petrik KL; Rajasekaran B; Wu M; Zhan Q
    Oncogene; 2002 Dec; 21(57):8696-704. PubMed ID: 12483522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation.
    Zhan Q; Fan S; Smith ML; Bae I; Yu K; Alamo I; O'Connor PM; Fornace AJ
    DNA Cell Biol; 1996 Oct; 15(10):805-15. PubMed ID: 8892753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage.
    Rathmell WK; Kaufmann WK; Hurt JC; Byrd LL; Chu G
    Cancer Res; 1997 Jan; 57(1):68-74. PubMed ID: 8988043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45.
    Zhan Q; Antinore MJ; Wang XW; Carrier F; Smith ML; Harris CC; Fornace AJ
    Oncogene; 1999 May; 18(18):2892-900. PubMed ID: 10362260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the G2/M transition by p53.
    Taylor WR; Stark GR
    Oncogene; 2001 Apr; 20(15):1803-15. PubMed ID: 11313928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin.
    Zimmermann M; Arachchige-Don AS; Donaldson MS; Dallapiazza RF; Cowan CE; Horne MC
    J Biol Chem; 2012 Jun; 287(27):22838-53. PubMed ID: 22589537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression.
    Jin S; Antinore MJ; Lung FD; Dong X; Zhao H; Fan F; Colchagie AB; Blanck P; Roller PP; Fornace AJ; Zhan Q
    J Biol Chem; 2000 Jun; 275(22):16602-8. PubMed ID: 10747892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of ATM-independent decatenation checkpoint function in human cells is secondary to inactivation of p53 and correlated with chromosomal destabilization.
    Kaufmann WK; Campbell CB; Simpson DA; Deming PB; Filatov L; Galloway DA; Zhao XJ; Creighton AM; Downes CS
    Cell Cycle; 2002; 1(3):210-9. PubMed ID: 12429935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
    Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1.
    Chang KL; Kung ML; Chow NH; Su SJ
    Biochem Pharmacol; 2004 Feb; 67(4):717-26. PubMed ID: 14757171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells.
    Bae I; Fan S; Bhatia K; Kohn KW; Fornace AJ; O'Connor PM
    Cancer Res; 1995 Jun; 55(11):2387-93. PubMed ID: 7757991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation.
    Davis TW; Wilson-Van Patten C; Meyers M; Kunugi KA; Cuthill S; Reznikoff C; Garces C; Boland CR; Kinsella TJ; Fishel R; Boothman DA
    Cancer Res; 1998 Feb; 58(4):767-78. PubMed ID: 9485033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Hydroxynonenal induces G2/M phase cell cycle arrest by activation of the ataxia telangiectasia mutated and Rad3-related protein (ATR)/checkpoint kinase 1 (Chk1) signaling pathway.
    Chaudhary P; Sharma R; Sahu M; Vishwanatha JK; Awasthi S; Awasthi YC
    J Biol Chem; 2013 Jul; 288(28):20532-46. PubMed ID: 23733185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation.
    Goi K; Takagi M; Iwata S; Delia D; Asada M; Donghi R; Tsunematsu Y; Nakazawa S; Yamamoto H; Yokota J; Tamura K; Saeki Y; Utsunomiya J; Takahashi T; Ueda R; Ishioka C; Eguchi M; Kamata N; Mizutani S
    Cancer Res; 1997 May; 57(10):1895-902. PubMed ID: 9157982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
    Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.